Stephen Hoge - 29 Aug 2025 Form 4 Insider Report for Moderna, Inc. (MRNA)

Role: President
Signature: /s/ James Dillon, as Attorney-in-Fact
Issuer symbol: MRNA
Transactions as of: 29 Aug 2025
Net transactions value: -$7,708
Form type: 4
Filing time: 02 Sep 2025, 17:20:12 UTC
Previous filing: 29 Aug 2025
Next filing: 01 Dec 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Hoge Stephen	President	C/O MODERNA, INC., 325 BINNEY STREET, CAMBRIDGE	/s/ James Dillon, as Attorney-in-Fact	02 Sep 2025	0001760669

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	MRNA	Common Stock	Options Exercise		+651	+0.04%		1,453,827	29 Aug 2025	Direct	F1
transaction	MRNA	Common Stock	Tax liability	$7,708	-315	-0.02%	$24.47	1,453,512	29 Aug 2025	Direct	F2
holding	MRNA	Common Stock						4,116	29 Aug 2025	By Valhalla, LLC
holding	MRNA	Common Stock						151,933	29 Aug 2025	By Trust	F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	MRNA	Restricted Stock Units	Options Exercise	$0	-651	-33%	$0.000000	1,304	29 Aug 2025	Common Stock	651		Direct	F1, F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Restricted stock units convert into common stock on a one-for-one basis.
F2	Represents shares withheld at the election of the Reporting Person to satisfy tax withholding obligations in connection with the vest of restricted stock units.
F3	These shares are owned directly by a trust for the benefit of Dr. Hoge's spouse and children, of which his spouse is a trustee. The reporting person disclaims Section 16 beneficial ownership of these securities, except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for Section 16 or any other purpose.
F4	25% of the shares subject to this restricted stock unit award vested on March 1, 2023 with the remainder vesting in twelve (12) equal quarterly installments thereafter.